表紙
市場調查報告書

中國的Thymopentin市場分析

Investigation Report on Chinese Thymopentin Market, 2018-2022

出版商 China Research and Intelligence 商品編碼 660258
出版日期 內容資訊 英文 30 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
中國的Thymopentin市場分析 Investigation Report on Chinese Thymopentin Market, 2018-2022
出版日期: 2018年07月05日內容資訊: 英文 30 Pages
簡介

本報告提供中國的Thymopentin的市場相關分析,整體市場規模趨勢(過去5年份)和國內價格趨勢,市場競爭模式 (各企業市場佔有率等),主要製造商的簡介,未來性的市場趨勢預測(今後5年份)等調查。

第1章 Thymopentin的相關概念

  • 適應症
  • 中國國內的Thymopentin的發展歷史

第2章 中國的Thymopentin市場概要

  • 對Thymopentin的政府認證
  • 主要製造商

第3章 中國國內的Thymopentin銷售趨勢 (過去5年份)

  • 銷售額 (以金額為準)
    • 整體總銷售額
    • 各地區的銷售額
  • 銷售量 (以數量為準)
    • 整體整體銷售量
    • 各地區的銷售量

第4章 中國的Thymopentin主要廠商的市場佔有率 (過去5年份)

  • 市場佔有率 (以金額為準)
  • 市場佔有率 (以數量為準)

第5章 Thymopentin市場趨勢:各劑型 (過去5年份)

  • 市場佔有率:各劑型 (以金額為準)
  • 市場佔有率:各劑型 (以數量為準)

第6章 在中國市場的Thymopentin的參考價格 (銷售價格):各企業

  • Hainan Zhonghe Pharmaceutical Co., Ltd. (商標名:Hexin)
  • Beijing SL Pharmaceutical Co., Ltd. (商標名:Ouning)
  • Beijing Sciecure Pharmaceutical Co., Ltd. (商標名:Tongda)
  • Wuhan Hualong Bio-pharmaceutical Co., Ltd. (商標名:Ruilineng)
  • Hybio Pharmaceutical Co., Ltd. (商標名:Hanning)
  • Sinopharm A-Think Pharmaceutical Co., Ltd. (商標名:Liertai)
  • Shanghai Huayuan Pharmacy (Ningxia) Shasai Pharmaceutical Co., Ltd. (商標名:Guole)
  • Yangtze River Pharmaceutical (Group) Co., Ltd. (商標名:Suwei)
  • 成都 DIAO Jiuhong Pharmaceutical Factory (商標名:Tiboding)
  • Henan Furen Huaiqingtang Pharmaceutical Co., Ltd.

第7章 中國國內的Thymopentin主要製造商

  • Hainan Zhonghe Pharmaceutical Co., Ltd.
  • Beijing SL Pharmaceutical Co., Ltd.
  • Beijing Sciecure Pharmaceutical Co., Ltd.
  • Wuhan Hualong Bio-pharmaceutical Co., Ltd.
  • Hybio Pharmaceutical Co., Ltd.
  • Sinopharm A-Think Pharmaceutical Co., Ltd.
  • Shanghai Huayuan Pharmacy (Ningxia) Shasai Pharmaceutical Co., Ltd.
  • Yangtze River Pharmaceutical (Group) Co., Ltd.
  • Chengdu DIAO Jiuhong Pharmaceutical Factory
  • Henan Furen Huaiqingtang Pharmaceutical Co., Ltd.

第8章 中國的Thymopentin市場未來展望 (今後5年份)

  • 市場規模的預測
  • 競爭模式的預測
目錄
Product Code: 1806298

Thymopentin is a two-way immune-regulator, i.e. it can handle both immune hypofunction and hyperfunction. The indications include chronic hepatitis B and primary or secondary T-cell deficiencies. Thymopentin can also help treat some autoimmune diseases and tumors.

As an important active component of human thymus hormone, Thymopentin is artificially synthesized and free of allergenic protein and reaction, which significantly enhances the effect of Thymopentin as a substitute for thymosin injections. Therefore, Thymopentin is a strong performer among thymosin drugs.

In 1985, Thymopentin for Injection was launched in Italy in the trade name of "Timunox". In 1997, Hainan Zhonghe Pharmaceutical Co., Ltd. First launched Thymopentin for Injection (trade name: Hexin), China's first two-way immunomodulator of synthetic polypeptide after independent research and development. The product once played an important role in the fight against SARS in 2003. Later, other enterprises including Beijing SL Pharmaceutical Co., Ltd. Were approved to produce Thymopentin. Because of a low technological barrier, there are many manufacturers and fierce competitions in the market. Thymopentin is only sold in China as a Chinese-style drug.

According to CRI, in 2017, the sales value of Thymopentin exceeded CNY 1 billion in the Chinese market dominated by Hainan Zhonghe Pharmaceutical Co., Ltd., Beijing SL Pharmaceutical Co., Ltd., Beijing Sciecure Pharmaceutical Co., Ltd. And Hybio Pharmaceutical Co., Ltd. The sales value of top 10 enterprises took up about 99% of the market. The sales value of Hainan Zhonghe ranked first with a market share over 30%.

It is expected that the Chinese Thymopentin still has large potentials to grow in the coming years.

Topics Covered::

  • Development of Chinese Thymopentin Market
  • Size of Chinese Thymopentin Market
  • Competition Pattern of Chinese Thymopentin Market
  • Thymopentin Prices in Chinese Thymopentin Market
  • Prospects of Chinese Thymopentin Market

Table of Contents

1 Relevant Concepts of Thymopentin

  • 1.1 Indications
  • 1.2 Development History of Thymopentin in China

2 Market Overview of Thymopentin in China

  • 2.1 Governmental Approval of Thymopentin in China
  • 2.2 Major Manufacturers

3 Sales of Thymopentin in China, 2013-2017

  • 3.1 Sales Value of Thymopentin
    • 3.1.1 Overall Sales Value
    • 3.1.2 Sales Value in Different Regions
  • 3.2 Sales Volume
    • 3.2.1 Overall Sales Volume
    • 3.2.2 Sales Volume in Different Regions

4 Investigation on Market Share of Major Thymopentin Manufacturers in China, 2013-2017

  • 4.1 Market Share by Sales Value
  • 4.2 Market Share by Sales Volume

5 Thymopentin in Different Dosage Forms, 2013-2017

  • 5.1 Market Share of Dosage Forms by Sales Value
  • 5.2 Market Share of Dosage Forms by Sales Volume

6 Reference Sale Price of Major Thymopentin Products in Chinese Market, 2017-2018

  • 6.1 Hainan Zhonghe Pharmaceutical Co., Ltd. (Trade Name: Hexin)
  • 6.2 Beijing SL Pharmaceutical Co., Ltd. (Trade Name: Ouning)
  • 6.3 Beijing Sciecure Pharmaceutical Co., Ltd. (Trade Name: Tongda)
  • 6.4 Wuhan Hualong Bio-pharmaceutical Co., Ltd. (Trade Name: Ruilineng)
  • 6.5 Hybio Pharmaceutical Co., Ltd. (Trade Name: Hanning)
  • 6.6 Sinopharm A-Think Pharmaceutical Co., Ltd. (Trade Name: Liertai)
  • 6.7 Shanghai Huayuan Pharmacy (Ningxia) Shasai Pharmaceutical Co., Ltd. (Trade Name: Guole)
  • 6.8 Yangtze River Pharmaceutical (Group) Co., Ltd. (Trade Name: Suwei)
  • 6.9 Chengdu DIAO Jiuhong Pharmaceutical Factory (Trade Name: Tiboding)
  • 6.10 Henan Furen Huaiqingtang Pharmaceutical Co., Ltd.

7 Major Thymopentin Manufacturers in China, 2013-2017

  • 7.1 Hainan Zhonghe Pharmaceutical Co., Ltd.
  • 7.2 Beijing SL Pharmaceutical Co., Ltd.
  • 7.3 Beijing Sciecure Pharmaceutical Co., Ltd.
  • 7.4 Wuhan Hualong Bio-pharmaceutical Co., Ltd.
  • 7.5 Hybio Pharmaceutical Co., Ltd.
  • 7.6 Sinopharm A-Think Pharmaceutical Co., Ltd.
  • 7.7 Shanghai Huayuan Pharmacy (Ningxia) Shasai Pharmaceutical Co., Ltd.
  • 7.8 Yangtze River Pharmaceutical (Group) Co., Ltd.
  • 7.9 Chengdu DIAO Jiuhong Pharmaceutical Factory
  • 7.10 Henan Furen Huaiqingtang Pharmaceutical Co., Ltd.

8 Prospects of Chinese Thymopentin Market, 2018-2022

  • 8.1 Forecast on Market Size
  • 8.2 Forecast on Competition Pattern

Selected Charts

  • Chart Governmental Approval of Thymopentin in China
  • Chart Sales of Thymopentin in China, 2013-2017
  • Chart Sales Value of Thymopentin in China, 2013- 2017
  • Chart Sales Value of Thymopentin in Regions of China, 2013-2017
  • Chart Sales Volume of Thymopentin in China, 2013- 2017
  • Chart Market Share and Sales Value of Hainan Zhonghe's Thymopentin in China, 2013-2017
  • Chart Market Share and Sales Value of Beijing SL's Thymopentin in China, 2013-2017
  • Chart Market Share and Sales Value of Beijing Sciecure's Thymopentin in China, 2013-2017
  • Chart Market Share and Sales Value of Hybio's Thymopentin in China, 2013-2017
  • Chart Market Share and Sales Value of Wuhan Hualong's Thymopentin in China, 2013-2017
  • Chart Prices of Wuhan Hualong's Thymopentin in Several Chinese Cities, 2017-2018
  • Chart Prices of Beijing Sciecure's Thymopentin in Several Chinese Cities, 2017-2018
  • Chart Prices of Beijing SL's Thymopentin in Several Chinese Cities, 2017-2018
  • Chart Forecast on Thymopentin's Sales in China, 2018-2022
Back to Top